Last reviewed · How we verify

NCT02028143: ICE

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

Completed NA Last updated 23 April 2018
What this trial tests

NA trial testing Biosense Webster irrigated tip catheter in Atrial Fibrillation in 20 participants. Completed in 1 January 2016.

Timeline
1 November 2013
Primary endpoint
1 January 2015
1 January 2016

Quick facts

Lead sponsorGregory Jones
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 November 2013
Primary completion1 January 2015
Estimated completion1 January 2016
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Gregory Jones

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Imaging Real Time within the Left atrial chamber Enhances safety and efficacy of Radiofrequency Ablation of Atrial Fibrillation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02028143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing